U.S. FDA Looks To India As Next Partner To Host Foreign Regulatory Offices
This article was originally published in PharmAsia News
Executive Summary
U.S. FDA is exploring whether to establish permanent regulatory offices in India, following the agency's announcement that it plans to do so in China, HHS Secretary Michael Leavitt said during a March 18 briefing in Washington, D.C., shortly after completing a trip to India